116 related articles for article (PubMed ID: 19372547)
1. Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4.
Nanni P; Nicoletti G; Palladini A; Astolfi A; Rinella P; Croci S; Landuzzi L; Monduzzi G; Stivani V; Antognoli A; Murgo A; Ianzano M; De Giovanni C; Lollini PL
Mol Cancer Ther; 2009 Apr; 8(4):754-61. PubMed ID: 19372547
[TBL] [Abstract][Full Text] [Related]
2. Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.
Astolfi A; De Giovanni C; Landuzzi L; Nicoletti G; Ricci C; Croci S; Scopece L; Nanni P; Lollini PL
Gene; 2001 Aug; 274(1-2):139-49. PubMed ID: 11675006
[TBL] [Abstract][Full Text] [Related]
3. A dysfunctional miR-1-TRPS1-MYOG axis drives ERMS by suppressing terminal myogenic differentiation.
Hüttner SS; Henze H; Elster D; Koch P; Anderer U; von Eyss B; von Maltzahn J
Mol Ther; 2023 Sep; 31(9):2612-2632. PubMed ID: 37452493
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.
Ciarapica R; Carcarino E; Adesso L; De Salvo M; Bracaglia G; Leoncini PP; Dall'agnese A; Verginelli F; Milano GM; Boldrini R; Inserra A; Stifani S; Screpanti I; Marquez VE; Valente S; Mai A; Puri PL; Locatelli F; Palacios D; Rota R
BMC Cancer; 2014 Feb; 14():139. PubMed ID: 24575771
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I has different effects on myogenin induction and cell cycle progression in human alveolar and embryonal rhabdomyosarcoma cells.
Tsuchiya K; Hosoi H; Misawa-Furihata A; Houghton PJ; Sugimoto T
Int J Oncol; 2007 Jul; 31(1):41-7. PubMed ID: 17549403
[TBL] [Abstract][Full Text] [Related]
6. Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness.
Chiappalupi S; Riuzzi F; Fulle S; Donato R; Sorci G
Carcinogenesis; 2014 Oct; 35(10):2382-92. PubMed ID: 25123133
[TBL] [Abstract][Full Text] [Related]
7. RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation.
Riuzzi F; Sorci G; Sagheddu R; Sidoni A; Alaggio R; Ninfo V; Donato R
J Cell Sci; 2014 Apr; 127(Pt 8):1699-711. PubMed ID: 24554430
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation.
Codenotti S; Faggi F; Ronca R; Chiodelli P; Grillo E; Guescini M; Megiorni F; Marampon F; Fanzani A
Cancer Lett; 2019 May; 449():135-144. PubMed ID: 30771426
[TBL] [Abstract][Full Text] [Related]
9. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
10. Regulation of myogenin expression in normal and transformed myogenic cell lines.
Arnold HH; Braun T; Bober E; Buchberger A; Winter B; Salminen A
Symp Soc Exp Biol; 1992; 46():37-51. PubMed ID: 1341049
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding motif protein 24 regulates myogenin expression and promotes myogenic differentiation.
Jin D; Hidaka K; Shirai M; Morisaki T
Genes Cells; 2010 Nov; 15(11):1158-67. PubMed ID: 20977548
[TBL] [Abstract][Full Text] [Related]
12. TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.
Zhu B; Zhang M; Byrum SD; Tackett AJ; Davie JK
Int J Cancer; 2014 Aug; 135(4):785-97. PubMed ID: 24470334
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Six1 leads to retardation of myogenic differentiation in C2C12 myoblasts.
Li Z; Deng D; Huang H; Tian L; Chen Z; Zou Y; Jin G; Wang J; Zhang Q; Wu L; Shen H
Mol Biol Rep; 2013 Jan; 40(1):217-23. PubMed ID: 23079703
[TBL] [Abstract][Full Text] [Related]
14. Identification of a regulatory function for an orphan receptor in muscle: COUP-TF II affects the expression of the myoD gene family during myogenesis.
Muscat GE; Rea S; Downes M
Nucleic Acids Res; 1995 Apr; 23(8):1311-8. PubMed ID: 7753622
[TBL] [Abstract][Full Text] [Related]
15. cAMP effects on myogenic gene expression in rhabdomyosarcoma cells.
Wasserman LM; Newsham I; Huang HJ; Cavenee WK
Exp Cell Res; 1996 Aug; 227(1):55-62. PubMed ID: 8806451
[TBL] [Abstract][Full Text] [Related]
16. TPA-induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors.
Bouché M; Senni MI; Grossi AM; Zappelli F; Polimeni M; Arnold HH; Cossu G; Molinaro M
Exp Cell Res; 1993 Sep; 208(1):209-17. PubMed ID: 8395398
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of myogenin and p21 in methylcholanthrene-induced mouse rhabdomyosarcomas.
Inoue M; Wu H
Int J Exp Pathol; 2006 Dec; 87(6):445-50. PubMed ID: 17222212
[TBL] [Abstract][Full Text] [Related]
18. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.
Tonin PN; Scrable H; Shimada H; Cavenee WK
Cancer Res; 1991 Oct; 51(19):5100-6. PubMed ID: 1717137
[TBL] [Abstract][Full Text] [Related]
19. Effect of Smad3-mediated transforming growth factor-beta1 signaling on satellite cell proliferation and differentiation in chickens.
Li X; McFarland DC; Velleman SG
Poult Sci; 2008 Sep; 87(9):1823-33. PubMed ID: 18753451
[TBL] [Abstract][Full Text] [Related]
20. PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis.
Graf Finckenstein F; Shahbazian V; Davicioni E; Ren YX; Anderson MJ
Oncogene; 2008 Mar; 27(14):2004-14. PubMed ID: 17922034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
